Vida Ventures @Vida_Ventures
Vida Ventures is a next-generation life sciences investment firm that is passionate about building and funding medical breakthroughs. vidaventures.com Boston, MA Joined December 2017-
Tweets197
-
Followers1K
-
Following18
-
Likes38
A2 Biotherapeutics announces the appointment of Jim Robinson as CEO and member of the Board of Directors. Jim Robinson’s experience leading biotech organizations will be an incredible asset to the company. Read more: bit.ly/3VzuYmb #VidaPortfolio #A2Bio
Today, @TectonicTx announced they have initiated the Phase 1B study for TX45, Tectonic’s long-acting Fc-relaxin fusion molecule. Congratulations, Tectonic! Learn more: bit.ly/3vke00q #VidaPortfolio
Today, @capstantx announced the successful closing of their $175M Series B financing! We are proud to continue supporting Capstan as they bring new therapeutic modalities to patients. bit.ly/492cpKu #VidaPortfolio #celltherapy
Today @ReCodeTx announced their recent collaboration with @intelliatx, offering an accelerated path to gene editing therapeutics. Excited for the treatment options this union will bring to patients with Cystic Fibrosis. Congrats, ReCode! bit.ly/3T0ikL8 #VidaPortfolio #CF
Congratulations to @KyvernaT on debuting on @Nasdaq, #IPO trading as $KYTX! We're proud to support their mission to revolutionize care for patients with autoimmune diseases. Learn more: bit.ly/3HVS4eC #VidaPortfolio #KYTX #celltherapy
Thrilled to see @AlteromeTx has been named in this year's list of 'Top Life Sciences Startups to Watch in 2024’. Congratulations, Alterome, on this recognition and what a great start to the year! Learn more: bit.ly/3TJPxv6#VidaPo… #NextGen2024
#AktisOncology announced that Matthew Roden, Ph.D., President and CEO of Aktis Oncology, will present at the 42nd Annual #JPMorgan Healthcare Conference in San Francisco, CA on Tuesday, January 9, 2024 at 10:30 a.m. PT. Learn more: prn.to/48DgsNf #JPM2024 #VidaPortfolio
Today, @TectonicTx announced the first human cohort has been dosed in their Fc-relaxin fusion program targeting the RXFP1 receptor. Congrats, Tectonic, on this exciting milestone! Learn more: bit.ly/3GkQd2g #VidaPortfolio #clinicalprogram #gpcr
Read @KyvernaT’s recent publication in #TheLancetNeurology, describing the groundbreaking first case of treatment on refractory Myasthenia Gravis patient using KYV-101, Kyverna’s CD19 CAR T-cell therapy for B-cell driven autoimmune diseases. prn.to/3FZ0yRl #VidaPortfolio
Way to go @mark_springel! Vida Senior Associate, Mark Springel, Ph.D., moderated an engaging panel discussion with top venture partners from funds across Boston, hosted by @SiliconVlyBank.
Today, @VolastraTx announced first patient dosed in a Phase I/II clinical trial of VLS-1488. This trial is a significant milestone in Volastra’s mission to help patients with hard-to-treat cancers. Congrats, Volastra! Read more: tinyurl.com/yb2y5urm #VidaPortfolio #CIN
Today, @VolastraTx announced first patient dosed in a Phase I/II clinical trial of VLS-1488. This trial is a significant milestone in Volastra’s mission to help patients with hard-to-treat cancers. Congrats, Volastra! Read more: tinyurl.com/yb2y5urm #VidaPortfolio #CIN
Today, @VigilNeuro announced first participant dosed in a Phase 1 clinical trial evaluating VG-3927, the first and only small molecule TREM2 agonist in the clinic for the potential treatment of Alzheimer’s disease. Read more: tinyurl.com/bdeccftm #VidaPortfolio
Join our Co-founder and Managing Director, Arjun Goyal, M.D. at the 2023 @FierceBiotech Summit on October 17th for a panel discussion “Autopsy of a Deal: Understand How an M&A Deal Comes Together.” For more info: tinyurl.com/479hv6z6
Today, @ScorpionTx presented promising pre-clinical data at the 2023 AACR conference, highlighting STX-241, their EGFR inhibitor for the treatment of ‘double mutant’ non-small cell lung cancer. Read more: bit.ly/45vHy7f #VidaPortfolio #NSCLC
#QuantaTherapeutics announced late-breaking data at the AACR conference, highlighting anti-tumor activity demonstrated by their KRAS inhibitors. Read more: bit.ly/48PBiKd #VidaPortfolio #KRAS
Today, @ScorpionTx announced the first patient has been dosed in Phase 1/2 trial designed for the treatment of Non-Small Cell Lung Cancer. Read more: bit.ly/46EIUgU #VidaPortfolio #PrecisionOncology
Congratulations to Dr. Drew Weissman, Scientific Co-Founder of #CapstanTherapeutics, for receiving the 2023 Nobel Prize in Medicine for his foundational discoveries that gave the world a vaccine to fight the COVID-19 pandemic! Read more: bit.ly/3LyuMgU #VidaPortfolio
Congratulations to Dr. Drew Weissman, Scientific Co-Founder of #CapstanTherapeutics, for receiving the 2023 Nobel Prize in Medicine for his foundational discoveries that gave the world a vaccine to fight the COVID-19 pandemic! Read more: bit.ly/3LyuMgU #VidaPortfolio
Today, Avalyn Pharma, a clinical-stage company focused on the development of inhalation therapies for pulmonary diseases, announced the closing of an oversubscribed $175 million Series C financing. Congrats, Avalyn! tinyurl.com/5n6jrv9f #VidaPortfolio #pulmonaryfibrosis
Congratulations, @affinit_tx, on being selected as a finalist in the Biotech Company of the Year category for this year’s Scrip Awards! @Citeline #VidaPortfolio #scripawards
Congratulations, @affinit_tx, on being selected as a finalist in the Biotech Company of the Year category for this year’s Scrip Awards! @Citeline #VidaPortfolio #scripawards
Today, @KyvernaT announced their novel CD19 #CARTCellTherapy was well tolerated by the first Lupus Nephritis patient in the U.S. to receive the dose. This innovative approach offers patients with #autoimmunediseases hope. Congrats, Kyverna! qrco.de/beLKir #VidaPortfolio
Sara Nayeem @SaraNayeem
11K Followers 2K Following Invest in emerging biopharma co's as EVP, Investments at Enavate Sciences. Prior NEA and Avoro Ventures. I post advice for biopharma exec's and emerging VCs.
David Grainger @sciencescanner
14K Followers 797 Following Biotech entrepreneur & Partner @Medicxi Advocate of virtual, asset-centric R&D. All opinions my own
Michael Torres @Mykalt45
5K Followers 5K Following PhD in Cancer Bio @utswnews. Entrepreneur. CEO @CrossBridgeBio. @ReCodeTX Co-founder & Former VP R&D. EIR @TMCInnovation. @NIH_OITE UGSP scholar.
Becky Pferdehirt @beckypferdehirt
3K Followers 785 Following Investor @a16zbiohealth 🧬. Previously BD, R&D @Amgen, R&D @Genentech. Proud alum of @Cal & @MIT. Girl mom. Coastsider.
BowTiedBiotech 🧪�.. @BowTiedBiotech
12K Followers 7K Following Tri-Weekly Biotech Updates: Public & Private Market Updates, Company Building, Financing, Exit Strategies, and Emerging Science Trends | Current: Biotech VC
Deepak Jha @dkjhaunc
3K Followers 5K Following Drug discovery, Biotech & Pharma. AIIMS, JNU, UNC-Chapel Hill, BCH/HMS alumnus. RT≠ endorsements; Tweets mine not employer’s. A Dilliwala 🇮🇳 in Boston 🇺🇸
Chordoma Foundation L.. @CFLabsResearch
40 Followers 115 Following Patient driven research laboratory 100% dedicated to accelerating cures for chordoma. A program of @ChordomaFDN.
Carol M @Carol_VictoriaW
38 Followers 349 Following Be Fearless in pursuit of what sets your soul on fire ~ Computational Biomedicine I Women in engineering | Venture Capital, Startups and Entrepreneurship
Patrick Malloy @mal99104
1 Followers 198 Following
Kevin Martelli @KevMartelli
512 Followers 518 Following The best thing a human being can do, is to help another human being know more - Charlie Munger
Cancer Research Horiz.. @CR_Horizons
2K Followers 2K Following We are @CR_UK’s #innovation arm. We strengthen #academia & #industry collaboration, bridging the gap between research and the market.
Fund Shack @FundShack1
90 Followers 1K Following The private capital podcast, featuring top private equity and venture capital fund managers, investors, plus M&A, corporate finance and governance.
(((Shiloh TD))) @Shilohtd
165 Followers 976 Following Definitely a small white dog sitting in a burlap sack, Also I do a lot of research.
Phil Chou @PhilCho87627784
62 Followers 250 Following
… @AethernCapital
186 Followers 294 Following
Maninjay Atianand @atianand_lab
397 Followers 824 Following PI @PittTweet @UPMCHillmanCC | New gene functions #RNA #microprotein
Anthony @anthonystaj
149 Followers 1K Following biotech adventurer. I moonlight as a Jason Momoa impersonator. ramen reviewer. die hard Detroit Lions fan
Ankoor Talwar @ankoortalwar
37 Followers 297 Following 🩺🥁🎾 Clinical Research Fellow @PennPlasticSurg
Addie Minerva @AddieMinerva
682 Followers 826 Following PhD candidate @PrincetonNeuro 🧠 with @Cate_cholamine & @IlanaWitten | @NSF fellow | biotech @NucleateHQ @NucleateNY | scicomm @pu_insights
Ankush Sharma @Biologynerd2
177 Followers 3K Following mTor || Preclinical Studies || Oncology Models
Chirag Kariya @Chirag_Kariya
220 Followers 2K Following Clinical Research & Drug Development | Alliance Management | Build Scientific Collaboration | Co-Founder Biotech Network
Annie Vemu @VemuAnnie
12 Followers 104 Following
朱凯旋 @zhu963396
26 Followers 857 Following
Salemmi @Salemmi298838
29 Followers 2K Following
Miriam Schwalm @miss_anthropia
413 Followers 2K Following MIT postdoc interested in the application of new imaging techniques to study brain-wide dynamics of neural activity
Vishwa Trivedi @aBiotechVC
48 Followers 154 Following Biotech VC @ Zynext Ventures. We are a new-age Venture Capital firm investing in seed and early-stage disruptive healthcare technologies.
Jassy Rolls @JassyR90753
19 Followers 28 Following
Lukasz Szczerbinski @l_szczerbinski
233 Followers 491 Following Physician-scientist. Postdoctoral Research Fellow at the Broad Institute of Harvard and MIT
OCD & AD Healer @Ocd_Healer
104 Followers 57 Following Only one solution for OCD and AD in the world, Looking for VC and Angel Investor to conquer OCD and AD around the world!! #OCD #AD #Parkinson #FTD #ALS #SPS
xeke @Zeke06438822
101 Followers 368 Following
Ian Block @iankblock
162 Followers 1K Following building businesses (bb) & looking for investors: deck - https://t.co/E9wWDSstQc
Watson Genomics @WatsonGenomics
70 Followers 1K Following
Jay Lee @lee_hj0906
4 Followers 11 Following
Christopher Smithmyer @ACriminalHisto1
170 Followers 751 Following Get a copy of the bestseller by one of the most educated men in the world. Writer for New Right Network and freelance.
Wenming Zhang @zhang_wenm40950
49 Followers 33 Following
RQMIS Inc. @rqmis_inc
396 Followers 2K Following RQMIS provides focused comprehensive regulatory, quality & clinical consulting to the global medical device, pharmaceutical, nutraceutical & cosmetic industries
Samy S @SamyS01197984
2 Followers 16 Following
Antrix @antrixmusic
74 Followers 614 Following
Mike Patten @blooee
104 Followers 1K Following Scotsman in NJ, passionate about biopharma & science helping patients
David K @djk246
0 Followers 56 Following
Damian Clarke-Bruce @DCB_BioPharma
312 Followers 608 Following Global Healthcare, Biotech, Pharmaceuticals, Board-member/GAICD
Mirae Asset Capital L.. @MAC_LifeScience
2 Followers 37 Following Mirae Asset Capital Life Science is the U.S. affiliate of Mirae Asset Financial Group dedicated to life science investment.
Rafal Piwowarczyk @rpiwowarcz
74 Followers 616 Following
NeuroX1 Inc. @neurox_1
423 Followers 2K Following Creating the next generation of therapeutics for neurodegenerative diseases.
Mahesh Balan @maheshbalan
391 Followers 1K Following CEO at Pravici. CRM, blockchain, cryptocurrency, decentralized Id and loyalty enthusiast. I can also be found at @[email protected]
greg osborne @gregosborn60826
0 Followers 2 Following
DEV Group @DEVgroup
1K Followers 381 Following A holding company covering the spectrum of security, investing, media, strategy, and technology that is accelerating disruptive innovation. | devgroup.eth
ReCode Therapeutics @ReCodeTx
495 Followers 162 Following ReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics.
Affini-T Therapeutics @affinit_tx
258 Followers 119 Following Right Targets. Right Cells. Right Place. Unlocking the power of T-cells against oncogenic driver mutations.
Vigil Neuroscience @VigilNeuro
338 Followers 116 Following Harnessing the power of microglia to improve the lives of patients, caregivers and families through transformative treatments for neurodegenerative diseases.
Kyverna Therapeutics @KyvernaT
142 Followers 29 Following We are bringing curative living medicines to life to free patients from the siege of autoimmune disease.
Praxis Medicines @PraxisMedicines
403 Followers 322 Following Praxis is translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance.
Tectonic Therapeutic @TectonicTx
80 Followers 27 Following Tectonic, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs).
Dyne Therapeutics @Dyne_tx
1K Followers 323 Following Advancing life-transforming therapies for serious muscle diseases. Community guidelines: https://t.co/0XslT2HWqg
Centessa Pharmaceutic.. @centessa
662 Followers 26 Following A new kind of pharmaceutical company delivering asset centricity at scale.
Scorpion Therapeutics @ScorpionTx
318 Followers 126 Following Broadening the reach and impact of precision medicine for more people with cancer.
Jeito @Jeito_life
334 Followers 173 Following Jeito is a global leading investment company. Our mission: identify & support the next generation of pioneering entrepreneurs in the field of medical innovation
Jordi Xiol @jordixiol
2K Followers 703 Following Biotech VC @YsiosCapital 💊 | Molecular biologist | Science & history blogger 📚
Allogene Therapeutics @AllogeneTx
2K Followers 107 Following A clinical-stage biotechnology company developing allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease. Guidelines https://t.co/QnzUmxajfE
Boston Consulting Gro.. @BCG
505K Followers 843 Following Official global account of Boston Consulting Group. Highlights of our work, initiatives, people, partnerships, and more. Also @BCGhenderson & @bcgx_
Third Rock Ventures @ThirdRockV
6K Followers 203 Following
5AM Ventures @5amVentures
2K Followers 70 Following Dedicated to taking a diversified, hands-on investment approach to creating value in early-stage life science companies
Jaideep Dudani @JaideepDudani
263 Followers 726 Following Portfolio Dev't @HIBiosciences and Investing at Monograph Capital. Prev. @Relay_Tx, @Vida_Ventures, @MIT, @kochinstitute, and @UCLA Bioengineering.
The New England Ventu.. @NewEnglandVC
7K Followers 1K Following We foster a collaborative, inclusive, & prosperous innovation ecosystem on behalf of New England's VC industry. Launched @Unpitch, #NEVYs, and more
Biomarker interview with @arjun__goyal co-founder and MD @Vida_Ventures. We chart Arjun’s path through medicine, science and #venture. Lessons learned during his time @HarvardHBS & @5amVentures, and how he thinks about #biotech in 2023. open.substack.com/pub/biomarker/…
We’re proud to announce we have in-licensed sovilnesib, a promising KIF18A inhibitor from @Amgen, in Phase 1 for ovarian, breast & other #cancer, alongside a $60M Series A financing to grow & accelerate our pipeline targeting #chromosomal_instability. More:bit.ly/3ZJnZpA
Really enjoyed writing this one endpts.com/backed-by-five…
We are excited to share an update on our lead programs targeting mutant PI3Kα and EGFR Exon 20. We look forward to advancing these and other programs as we progress toward our goal of delivering transformational outcomes to patients. #precisiononocology scorpiontx.com/scorpion-thera…
Congrats to our CEO @ElvireGouze on receiving the @EYnews Entrepreneur Of The Year™ Southeast France 2021 Award in the #startup category, for her work transforming the treatment paradigm for patients with rare skeletal disorders. Learn more here: bit.ly/2Wq46bY
Tectonic: This biotech wants to do exactly what its name suggests: make tectonic shifts in GPCR drug discovery. The target plays a role in multiple functions throughout the body, but the group of proteins is still relatively and largely untapped fiercebiotech.com/special-report…
STARTING SOON: The biotech 2.0 era has arrived. And with that backdrop, we'll discuss the top 11 companies supercharging a new generation of startups in 2021. Register for our webinar at 3 pm ET using the link below. There's no cost to attend! eleven21.endpts.com
Today, we're pleased to announce positive topline data from the Phase 2a part of our proof-of-concept study evaluating SerpinPC in severe #hemophilia A and B patients. Read more here: bit.ly/3jRSVSh $CNTA
CONGRATULATIONS to our TECH ENTREPRENEUR Advance Award winner, @arjun__goyal! Dr Goyal is a venture capitalist in personalised medicine, and Co-Founder and Managing Director at Vida Ventures in Boston and Los Angeles, USA. #AdvanceAwards2021 Read more > advance.org/profile/dr-arj…
Whether it’s next-gen cell therapies or even the once oft-forgotten field of vaccines, our list of the 20 most influential R&D executives runs the gamut on innovation. endpts.com/from-bench-to-…
#AdvanceAwards2021 | Introducing Dr Arjun Goyal (@arjun__goyal), Advance TECHNOLOGY & ENTREPRENEURSHIP Award Finalist. #BornGlobal Read more > advance.org/profile/dr-arj… … @Vida_Ventures @5amVentures @AusintheUS @UniMelb @UniofOxford @Cambridge_Uni @HarvardHBS
“I think we’re experiencing a true renaissance in neuroscience,” Stefan Vitorovic, co-founder and managing director at Vida Ventures, told Endpoints News. endpts.com/vigil-neurosci…
We are thrilled to welcome an all-star group of investors to our $90 million Series B led by @Vida_Ventures. We are also proud to announce #ALSP as the first indication for VGL101. #TREM2 #CSF1R #Alzheimers #Boston #Biotech #Raredisease #VigilantForYou bwnews.pr/3k7l32C
We are excited to announce the appointment of Axel Hoos, M.D., Ph.D. as CEO of Scorpion Therapeutics. bit.ly/3hpx7wh
Vida Ventures closed its third investment fund at a whopping $825 million — its largest yet — as the ever-expanding VC firm hits 30 companies in its portfolio developing new routes to hard-to-treat diseases. endpts.com/arie-belldegru…
The 2021 issue of the LA 500 — a list of the 500 most influential leaders and impactful executives in Los Angeles — is here. Given the challenges of the last year, this list may be the most impressive to date. View the full list here: labusinessjournal.com/news/2021/may/…
Now trading: We're proud to announce the pricing of our IPO. $CNTA is now on @Nasdaq. Thank you to everyone who has supported our mission! investors.centessa.com/news-releases/…
Welcome to the @Nasdaq family, @centessa! Now trading: #NasdaqListed $CNTA.
Alise Reicin has just made a key addition to her top team at Tectonic, the new Boston upstart kickstarted into existence by billionaire Harvard scientist Tim Springer. endpts.com/alise-reicin-r…
Allogene, the next-gen CAR-T company out to prove that their off-the-shelf approach to treating blood cancers is just as good as the autologous pioneers — or potentially even better — is out with a fresh set of data in the leadup to #ASCO21. endpts.com/allogene-sets-…
There’s a whole generation of pioneers who have been breaking new paths in R&D for decades. This is our tip of the hat for what they’ve done. And what they promise to do. endpts.com/legacies-60-bi…
Trends for United States
You might like
